Patent · US Active

Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses

US8119643B2 · kind B2 · utility

1Cited by
1References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 20, 2007
Grant dateFeb 21, 2012
Priority date
Expiry dateMar 20, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Biologically active chemical compounds, namely benzoimidazolyl-pyrazine derivatives and structurally related compounds, are disclosed herein. Such compounds include those represented by structural formula (II):and as described in further detail within. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.